153 related articles for article (PubMed ID: 8834518)
21. Epstein-Barr virus in non-Hodgkin's lymphomas of the upper respiratory tract: association with sinonasal localization and expression of NK and/or T-cell antigens by tumour cells.
Kanavaros P; Briere J; Lescs MC; Gaulard P
J Pathol; 1996 Mar; 178(3):297-302. PubMed ID: 8778335
[TBL] [Abstract][Full Text] [Related]
22. Frequent presence of latent Epstein-Barr virus infection in peripheral T cell lymphomas. A review.
Anagnostopoulos I; Hummel M; Stein H
Leuk Lymphoma; 1995 Sep; 19(1-2):1-12. PubMed ID: 8574154
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
[TBL] [Abstract][Full Text] [Related]
24. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies.
Harabuchi Y; Imai S; Wakashima J; Hirao M; Kataura A; Osato T; Kon S
Cancer; 1996 May; 77(10):2137-49. PubMed ID: 8640683
[TBL] [Abstract][Full Text] [Related]
25. Angiocentric immunoproliferative lesions of the lymph node.
Takeshita M; Akamatsu M; Ohshima K; Suzumiya J; Kikuchi M; Kimura N; Uike N; Okamura T
Am J Clin Pathol; 1996 Jul; 106(1):69-77. PubMed ID: 8701936
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
[TBL] [Abstract][Full Text] [Related]
27. Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene.
Suzumiya J; Ohshima K; Takeshita M; Kanda M; Kawasaki C; Kimura N; Tamura K; Kikuchi M
Leuk Lymphoma; 1999 Nov; 35(5-6):567-78. PubMed ID: 10609794
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus subtype distribution in angioimmunoblastic lymphadenopathy.
Borisch B; Caioni M; Hurwitz N; Dommann-Scherrer C; Odermatt B; Waelti E; Laeng RH; Kraft R; Laissue J
Int J Cancer; 1993 Nov; 55(5):748-52. PubMed ID: 8244571
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated primary gastrointestinal lymphoma in non-immunocompromised patients in Korea.
Lee SS; Jang JJ; Cho KJ; Khang SK; Kim CW
Histopathology; 1997 Mar; 30(3):234-42. PubMed ID: 9088952
[TBL] [Abstract][Full Text] [Related]
30. Lymphomatoid granulomatosis: evidence that some cases represent Epstein-Barr virus-associated B-cell lymphoma.
Nicholson AG; Wotherspoon AC; Diss TC; Singh N; Butcher DN; Pan LX; Isaacson PG; Corrin B
Histopathology; 1996 Oct; 29(4):317-24. PubMed ID: 8910039
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China.
van Gorp J; Weiping L; Jacobse K; Liu YH; Li FY; De Weger RA; Li G
J Pathol; 1994 Jun; 173(2):81-7. PubMed ID: 7522272
[TBL] [Abstract][Full Text] [Related]
32. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas.
Korbjuhn P; Anagnostopoulos I; Hummel M; Tiemann M; Dallenbach F; Parwaresch MR; Stein H
Blood; 1993 Jul; 82(1):217-23. PubMed ID: 8391874
[TBL] [Abstract][Full Text] [Related]
33. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
34. No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue.
Wilms T; Khan G; Coates PJ; Sgaramella N; Fåhraeus R; Hassani A; Philip PS; Norberg Spaak L; Califano L; Colella G; Olofsson K; Loizou C; Franco R; Nylander K
PLoS One; 2017; 12(9):e0184201. PubMed ID: 28926591
[TBL] [Abstract][Full Text] [Related]
35. Low incidence of Epstein-Barr virus presence in primary cutaneous T-cell lymphoproliferations.
Anagnostopoulos I; Hummel M; Kaudewitz P; Korbjuhn P; Leoncini L; Stein H
Br J Dermatol; 1996 Feb; 134(2):276-81. PubMed ID: 8746341
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus in cutaneous lymphomatoid granulomatosis.
Angel CA; Slater DN; Royds JA; Nelson SN; Bleehen SS
Histopathology; 1994 Dec; 25(6):545-8. PubMed ID: 7698731
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr virus and gastrointestinal lymphomas in Korea.
Yang WI; Cho MS; Tomita Y; Ohsawa M; Aozasa K
Yonsei Med J; 1998 Jun; 39(3):268-76. PubMed ID: 9664833
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico.
Elenitoba-Johnson KS; Zarate-Osorno A; Meneses A; Krenacs L; Kingma DW; Raffeld M; Jaffe ES
Mod Pathol; 1998 Aug; 11(8):754-61. PubMed ID: 9720504
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features.
Beaty MW; Toro J; Sorbara L; Stern JB; Pittaluga S; Raffeld M; Wilson WH; Jaffe ES
Am J Surg Pathol; 2001 Sep; 25(9):1111-20. PubMed ID: 11688570
[TBL] [Abstract][Full Text] [Related]
40. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract.
Chan JK; Yip TT; Tsang WY; Ng CS; Lau WH; Poon YF; Wong CC; Ma VW
Am J Surg Pathol; 1994 Sep; 18(9):938-46. PubMed ID: 8067515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
